Pure Global AI
Disease / condition

Esophageal Cancer clinical trials

Free access to 407 studies10+ countriesUpdated daily74 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
407
Total trials
10+
Countries
10+
Sponsors
74
Recruiting
By phase
N/A180
Phase 2107
Phase 136
Phase 333
Early Phase 132
By status
Completed162
Recruiting74
Unknown66
Not yet recruit...50
Terminated32
Top countries
China111
United States of America101
Japan42
Taiwan21
Netherlands11
Top sponsors
National Taiwan Un...12
Memorial Sloan Ket...11
Chinese Academy of...9
Alliance for Clini...8
M.D. Anderson Canc...8
Recent trials
Latest clinical trials for Esophageal Cancer
18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer
M.D. Anderson Cancer Center · United States of America
NCT06414902Not yet recr...
Phase
Phase 1
Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer
Sichuan University · China
NCT06403878Recruiting
Phase
Phase 2
Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS)
Shanghai Chest Hospital · China
NCT06385730Not yet recr...
Phase
Phase 2
Conebeam CT-based Online Adaptive Radio-Therapy for Esophageal Cancer (ARTEC)
Insel Gruppe AG, University Ho... · Switzerland
NCT06361043Recruiting
An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).
Ruijin Hospital
NCT06339060Not yet recr...
Phase
Phase 3
Preoperative Arterial Embolization Before Oncologic Esophagectomy as a Technique for Ischemic Gastric Conditioning
Centre Hospitalier Universitai... · France
NCT06312839Not yet recr...
BReath Hold TecHniquEs for Radiotherapy of Esophageal Carcinoma
University Medical Center Gron... · Netherlands
NCT06317272Terminated
Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma
Tongji University · China
NCT06304350Recruiting
Phase
Phase 2
BEST-RPP Pilot: Screening for Esophageal Cancer in Rural Oregon Without an Endoscopy
OHSU Knight Cancer Institute · United States of America
NCT06335966Recruiting
A Study of the Tumor Microenvironment Affecting the Efficacy of Immunotherapy for Esophageal Cancer
Renmin Hospital of Wuhan Unive... · China
NCT06219031Completed
Risk Factors of Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to Neoadjuvant Chemoradiotherapy
Sun Yat-sen University · China
NCT06061263Recruitment ...
Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC
Tianjin Medical University Can... · China
NCT06061146Recruiting
Phase
Phase 2
CPAP for Esophageal Cancer With Radiotherapy
Sheba Medical Center · Israel
NCT06037902Recruiting
Submucosal Saline Injection Followed by Endoscopic Ultrasound
Sun Yat-sen University · China
NCT06022978Recruiting
Assessment of Sleep Quality and Mobilization Using the Actigraph in Postoperative Patients with Esophageal Cancer: A Prospective Observational Study
Okayama University Graduate Sc... · Japan
UMIN000051517Not yet recr...
Phase
Not Applicable
Endoscopic Submucosal Dissection Versus Esophagectomy for Early Esophageal Carcinoma
Changhai Hospital · China
NCT06060106Completed
Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
Renmin Hospital of Wuhan Unive... · China
NCT05894369Recruiting
Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer
Peking University · China
NCT05866510Recruiting
Phase
Phase 2
PET/MRI in Predicting the Outcome of Neoadjuvant Chemoradiotherapy With Esophagectomy in Esophageal Cancer Patients
Chang Gung Memorial Hospital · Taiwan
NCT05855291Completed
The Role of PET/MRI in Predicting the Outcome of Definitive Chemoradiotherapy for Esophageal Cancer Patients
Chang Gung Memorial Hospital · Taiwan
NCT05855278Completed
About this profile

Access comprehensive clinical trial information for Esophageal Cancer through Pure Global AI's free database. This collection includes 407 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 74 trials are actively recruiting participants.

Research for Esophageal Cancer is being conducted in China, United States of America, Japan and 7+ other countries. Leading sponsors include National Taiwan University Hospital and Memorial Sloan Kettering Cancer Center. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 407 clinical trials studying Esophageal Cancer, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include National Taiwan University Hospital, Memorial Sloan Kettering Cancer Center, Chinese Academy of Medical Sciences, among others.